| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.22 | 3e-09 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.23 | 7e-07 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.22 | 6e-06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |